Cerecor

company

About

Cerecor discovers, develops and commercializes neuroscience drugs.

  • 11 - 50

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$20M
Industries
Biopharma,Biotechnology,Health Care
Founded date
Jan 1, 2011
Number Of Employee
11 - 50
Operating Status
Active

Cerecor is a biopharmaceutical company focused on becoming a leader in the development and commercialization of treatments for immunologic, immuno-oncologic and rare genetic disorders. The company is advancing its clinical-stage pipeline of innovative therapies that address unmet patient needs within rare and orphan diseases. The company's rare disease pipeline includes CERC-801, CERC-802 and CERC-803, which are in development for congenital disorders of glycosylation and CERC-006, an oral mTORc1/c2 inhibitor in development for the treatment of complex lymphatic malformations. The company is also developing two monoclonal antibodies, CERC-002, and CERC-007. CERC-002 targets the cytokine LIGHT (TNFSF14) and is in clinical development for treatment of severe pediatric-onset Crohn's disease and COVID-19 acute respiratory distress syndrome. CERC-007 targets the cytokine IL-18 and is in clinical development for the treatment of Still’s disease (adult onset Still’s disease (AOSD) and systemic juvenile idiopathic arthritis (sJIA)) and multiple myeloma (MM). CERC-006, 801, 802 and 803 have all received Orphan Drug Designation and Rare Pediatric Disease Designation, which makes all four eligible for a priority review voucher upon FDA approval.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$31M
Cerecor has raised a total of $31M in funding over 2 rounds. Their latest funding was raised on Aug 2, 2021 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 2, 2021 Post-IPO Debt $10M 1 Horizon Technology Finance Detail
Jun 7, 2021 Post-IPO Debt $20M 1 Horizon Technology Finance Detail
Apr 11, 2016 Grant $1M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
2
Cerecor is funded by 2 investors. Horizon Technology Finance and National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
Horizon Technology Finance Yes Post-IPO Debt
National Institutes of Health Grant